| Utility: T cell receptors and immune therapy using the same Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 | 7 Dec 2017 | 29 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 | 11 Sep 2020 | 24 Dec 2020 |
| Utility: METHOD OF TREATING WITH A PEPTIDE Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 | 10 Sep 2020 | 24 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 | 10 Sep 2020 | 24 Dec 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 | 30 Jun 2020 | 24 Dec 2020 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 30 Jun 2020 | 22 Dec 2020 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 30 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 18 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 12 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 12 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 22 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 22 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 22 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 11 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 22 Dec 2020 | 11 May 2020 | 22 Dec 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 | 30 Jun 2020 | 17 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 | 29 Jun 2020 | 10 Dec 2020 |
| Utility: SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 | 4 Jun 2020 | 10 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 | 29 Jun 2020 | 3 Dec 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 8 Sep 2025 Issue date: 24 Nov 2020 | 24 Jun 2020 | 24 Nov 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 | 6 May 2020 | 19 Nov 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 | 29 Jun 2020 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 | 24 Jun 2020 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 | 1 May 2020 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 | 16 Dec 2019 | 17 Nov 2020 |
| Utility: Anti-WT1/HLA-specific antibodies Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 | 7 Oct 2016 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 | 29 May 2020 | 10 Nov 2020 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 | 29 May 2020 | 10 Nov 2020 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS Filling date: 8 Sep 2025 Issue date: 5 Nov 2020 | 3 Jun 2020 | 5 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers Filling date: 8 Sep 2025 Issue date: 3 Nov 2020 | 21 May 2018 | 3 Nov 2020 |
| Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 29 Jun 2020 | 29 Oct 2020 |
| Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 29 Jun 2020 | 29 Oct 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 29 Jun 2020 | 29 Oct 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 26 Jun 2020 | 29 Oct 2020 |
| Utility: TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 | 9 Mar 2020 | 29 Oct 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 | 3 Jun 2020 | 27 Oct 2020 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 | 20 Apr 2020 | 27 Oct 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 | 13 Feb 2020 | 27 Oct 2020 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER Filling date: 8 Sep 2025 Issue date: 22 Oct 2020 | 5 Jun 2020 | 22 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
